Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Circ Res. 2008 May 29;103(1):80–88. doi: 10.1161/CIRCRESAHA.108.176057

Figure 5.

Figure 5

Role of COX-1 in EPC proliferation. A. EPCs (20000/well of 24-well plate, seeded in triplicate) were cultured in EGM-2 in the absence (control) or presence of indomethacin (Indo), or Indo + iloprost (ilopr) for 3 days. The number of attached cells in each well was counted in a hemocytometer. A: n=7. *P<0.05, compared to the other 2 groups. **P<0.05, compared to control. B: EPCs were treated with the indicated concentrations of SC560 or NS398 for 3 days. n=3, *P<0.05, compared with EGM-2 alone (control). **P<0.05, compared to other 4 groups.

HHS Vulnerability Disclosure